Abstract:Background: Hepatitis C virus (HCV) infection causes slowly progressive liver disease. Therefore, the full impact of HCV infection after transplantation may require 5-10 years of follow-up. Methods: We have previously reported the effect of HCV infection, acquired from the donor (study 1) or acquired before transplantation (study 2), on the incidence of liver disease, and on patient and graft survival with a median follow-up of 3-5 years. In study 1, we compared 24 recipients of organs from donors who were positive to antibody to HCV (anti-HCV) to 74 recipients of organs from anti-HCV-negative donors. In study 2, we compared 23 anti-HCV-positive recipients to 80 anti-HCV-negative recipients of kidneys from anti-HCV-negative donors. In this report, we extend the median follow-up period for patient and graft survival to 6-7 years, and discuss the implications of our finding on policies for organ procurement. Results: In study 2, after extended follow-up, there continued to be no significant difference between groups with respect to graft loss, but mortality remained significantly higher among recipients with anti-HCV before transplantation. Compared with recipients without anti-HCV before transplantation, the relative risk of graft loss among recipients with anti-HCV before transplantation was 1.30 (0.66-2.58), the relative risk of death was 2.60 (1.15-5.90), and the relative risk of death due to sepsis was 6.30 (1.99-20). In study 1, after extended follow-up, there continued to be no significant differences between groups, with respect to graft loss or death. Compared with recipients of organs from anti-HCV-negative donors, the relative risk of graft loss among recipients of organs from anti-HCV-positive donors was 0.95 (0.54-1.67), and the relative risk of death was 1.00 (0.49-2.02). Conclusions: The two studies presented in this report provide an apparent paradox, with respect to the impact of HCV infection acquired at the time of transplantation versus before transplantation on posttransplantation clinical outcomes. However, the increased mortality among recipients who acquired HCV infection before transplantation, but not among recipients who acquired HCV at the time of transplantation, could be explained by the longer duration of HCV infection in the former group. These findings are consistent with the known slowly progressive nature of HCV infection. However, in the absence of definitive evidence for an adverse effect on patient or graft survival, we believe that the decision to accept a kidney from an anti-HCV-positive donor should be made by the patient, after discussion with the treating physician.

Identification of HIV infection in two solid organ recipients three years after transplantation

Identificación de infección por el virus de la inmunodeficiencia humana en dos receptores de órgano sólido tres años después del trasplante

Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety

Longitudinal analysis of viral dynamics in HIV+-to-HIV+ HOPE Act kidney-transplant recipients

Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening

Does Antiretroviral Therapy Prevent Human T-Lymphotropic Virus 1 Transmission From a Seropositive Donor to a Kidney Transplant Recipient? A Case Report and Literature Review

HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants

Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management

[GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)]

Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV

Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

Policies and practice of solid organ donation amongst people living with HIV in Canada: time for education and re-evaluation

Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China

Safety of Kidney Transplantation from Donors with HIV

HIV-Positive Organ Donation as Standard of Care in Transplantation

Reactivation of a transplant recipient's inherited human herpesvirus 6 and implications to the graft

Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (two Case Reports).

Donor-Derived Human Parvovirus B19 Infection in Kidney Transplantation

Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement

Beyond Immunity: Challenges in Kidney Retransplantation Among Persons Living With HIV